Search clinical trials for: Memantine Hydrochloride
Total 7564 results
-
First People's Hospital of HangzhouCttqUnknown
-
Chifeng Municipal HospitalUnknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
Idorsia Pharmaceuticals Ltd.Completed
-
FDA Office of Orphan Products DevelopmentSt. Luke's-Roosevelt Hospital CenterCompletedErythropoietic Protoporphyria
-
Sumithira VasuKiadis PharmaRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blasts 10 Percent or More of Bone Marrow Nucleated Cells | Allogeneic Stem Cell Transplant RecipientUnited States
-
Eximias PharmaceuticalCompletedLiver CancerUnited States, Canada, Puerto Rico
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Genzum Life SciencesCompleted
-
Taro Pharmaceuticals USACompleted
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
Paula Silverman, MDNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Roswell Park Cancer InstituteCompletedEsophageal CancerUnited States
-
University College, LondonRoche Pharma AG; Cancer Research UKCompletedLung CancerUnited Kingdom
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States
-
Sihuan Pharmaceutical Holdings Group Ltd.Completed
-
NCIC Clinical Trials GroupCompletedPancreatic CancerUnited States, Canada, Australia, Singapore, Belgium, United Kingdom, Israel, New Zealand, China, Germany, Brazil, Poland, Italy, Argentina, Romania, Greece, Chile, Hong Kong, Mexico
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Japan Multinational Trial OrganizationCompleted
-
Shandong Lanjin Pharmaceuticals Co.,LtdUnknownNeoplasms | Leukemia | Chronic Lymphocytic LeukemiaChina
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
University of ChicagoCompletedTrichotillomania (Hair-Pulling Disorder) | DermatillomaniaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Neurotoxicity | Cognitive/Functional EffectsUnited States, Canada
-
Merz Pharmaceuticals GmbHTerminated
-
University of ChicagoNational Cancer Institute (NCI)CompletedMalignant Peritoneal MesotheliomaUnited States
-
Taro Pharmaceuticals USATerminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)WithdrawnExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone LymphomaUnited States
-
Laboratoires TheaActive, not recruitingOcular Hypertension | GlaucomaUnited States
-
TelikTerminatedSevere Chronic NeutropeniaUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage II Pancreatic CancerUnited States
-
CephalonCompletedNon-Hodgkin's Lymphoma (NHL)United States, Belgium, Israel
-
Mayo ClinicNational Comprehensive Cancer NetworkCompletedStage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Refractory Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Stage IV Intrahepatic Bile Duct Cancer AJCC v8 | Stage IVB Gallbladder... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingSolid NeoplasmUnited States
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Brigham and Women's HospitalCompletedErythropoietic Protoporphyria
-
University of California, San DiegoRecruitingSchizophrenia | Schizoaffective DisorderUnited States
-
National Cheng-Kung University HospitalNational Institutes of Health (NIH)Completed
-
TakedaTerminatedDiabetes Mellitus, Type 2
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSmall Cell Lung CarcinomaChina
-
Sumitomo Pharma Co., Ltd.TerminatedSmall-cell Lung CancerJapan
-
University Health Network, TorontoCompletedPancreatic CancerCanada
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
BioCryst PharmaceuticalsCompletedLeukemia, Lymphocytic, ChronicUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States